(UTHR) United Therapeutics - Performance -1.5% in 12m
UTHR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
61.39%
#7 in Peer-Group
Rel. Strength
39.55%
#4602 in Stock-Universe
Total Return 12m
-1.47%
#60 in Peer-Group
Total Return 5y
149.14%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 12.9 |
| P/E Forward | 12.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 410.00 USD |
| 52 Week Low | 276.47 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 7.80 |
| Buy/Sell Signal +-5 | 0.27 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: UTHR (-1.5%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
9.2% | 80.8% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.02% | -1.47% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
10.1% | 2.09% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.05% | 33.4% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.43% | -8.71% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
10.5% | 38.9% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
-0.15% | 37.3% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.39% | 16% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: UTHR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for UTHR
| Total Return (including Dividends) | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.02% | 7.80% | 1.73% |
| 3 Months | -7.22% | -2.75% | 8.59% |
| 12 Months | -1.47% | -10.76% | 11.46% |
| 5 Years | 149.14% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | UTHR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.6% | 84.2% | 69.9% |
| 3 Months | 7.2% | -2.8% | 69.3% |
| 12 Months | -30.4% | -77.8% | 43.2% |
| 5 Years | 91.1% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #168 | -14.68% | -9.59% |
| 3 Month | #111 | -4.59% | -14.56% |
| 12 Month | #60 | 10.41% | -11.60% |
| 5 Years | #9 | 205.89% | 19.14% |
FAQs
Does United Therapeutics (UTHR) outperform the market?
Yes,
over the last 12 months UTHR made -1.47%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.76%.
Over the last 3 months UTHR made -7.22%, while XBI made -2.75%.
Performance Comparison UTHR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
UTHR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.7% | -9.8% | -21.1% | -13% |
| US NASDAQ 100 | QQQ | -12.5% | -10.2% | -21.3% | -13% |
| German DAX 40 | DAX | -9.8% | -7.4% | -36.5% | -30% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.7% | -7.1% | -21.6% | -14% |
| Hongkong Hang Seng | HSI | -14.1% | -13.8% | -38% | -28% |
| India NIFTY 50 | INDA | -11.5% | -8.1% | -19.7% | -1% |
| Brasil Bovespa | EWZ | -14.6% | -7.4% | -38.3% | -9% |
UTHR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.9% | -10.4% | -23.9% | -25% |
| Consumer Discretionary | XLY | -12.8% | -6.4% | -12% | -20% |
| Consumer Staples | XLP | -12.1% | -9.3% | -21.7% | -10% |
| Energy | XLE | -18.7% | -10.7% | -22% | -4% |
| Financial | XLF | -10.5% | -5.8% | -23.3% | -26% |
| Health Care | XLV | -14.3% | -11.3% | -19.1% | 4% |
| Industrial | XLI | -11.5% | -9% | -26.3% | -20% |
| Materials | XLB | -12.6% | -9.5% | -20.6% | -1% |
| Real Estate | XLRE | -13.1% | -10% | -21.2% | -14% |
| Technology | XLK | -13.4% | -10.8% | -22.1% | -8% |
| Utilities | XLU | -13.3% | -10.2% | -28.2% | -21% |
| Aerospace & Defense | XAR | -12.8% | -16.1% | -39.8% | -43% |
| Biotech | XBI | -12.3% | -15.8% | -11.2% | 9% |
| Homebuilder | XHB | -12.1% | -1.1% | -4.5% | 9% |
| Retail | XRT | -9.2% | -9.2% | -13.1% | -2% |
UTHR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -25.4% | -23.3% | -29.8% | -7% |
| Natural Gas | UNG | -8.3% | 2% | -36.7% | 17% |
| Gold | GLD | -16.7% | -13.6% | -51.2% | -50% |
| Silver | SLV | -13.9% | -18.2% | -40.5% | -26% |
| Copper | CPER | -11.5% | -9.2% | -35.7% | -9% |
UTHR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -14.2% | -8.9% | -19.5% | 3% |
| iShares High Yield Corp. Bond | HYG | -13.1% | -8.4% | -24.6% | -10% |